Targeting PI3K in cancer: mechanisms and advances in clinical trials

J Yang, J Nie, X Ma, Y Wei, Y Peng, X Wei - Molecular cancer, 2019 - Springer
Abstract Phosphatidylinositol-3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR)
signaling is one of the most important intracellular pathways, which can be considered as a …

Renal cell carcinoma as a metabolic disease: an update on main pathways, potential biomarkers, and therapeutic targets

NA di Meo, F Lasorsa, M Rutigliano, D Loizzo… - International Journal of …, 2022 - mdpi.com
Clear cell renal cell carcinoma (ccRCC) is the most frequent histological kidney cancer
subtype. Over the last decade, significant progress has been made in identifying the genetic …

[HTML][HTML] The PI3K/AKT pathway in obesity and type 2 diabetes

X Huang, G Liu, J Guo, Z Su - International journal of biological …, 2018 - ncbi.nlm.nih.gov
Obesity and type 2 diabetes mellitus are complicated metabolic diseases that affect multiple
organs and are characterized by hyperglycaemia. Currently, stable and effective treatments …

Crosstalk between circRNAs and the PI3K/AKT signaling pathway in cancer progression

C Xue, G Li, J Lu, L Li - Signal transduction and targeted therapy, 2021 - nature.com
Circular RNAs (circRNAs), covalently closed noncoding RNAs, are widely expressed in
eukaryotes and viruses. They can function by regulating target gene expression, linear RNA …

[HTML][HTML] The PI3K/AKT/mTOR signaling pathway in osteoarthritis: a narrative review

K Sun, J Luo, J Guo, X Yao, X Jing, F Guo - Osteoarthritis and cartilage, 2020 - Elsevier
Osteoarthritis (OA) is a complicated degenerative disease that affects whole joint tissue.
Currently, apart from surgical approaches to treat late stage OA, effective treatments to …

The PI3K/Akt pathway in meta-inflammation

M Acosta-Martinez, MZ Cabail - International journal of molecular …, 2022 - mdpi.com
Obesity is a global epidemic representing a serious public health burden as it is a major risk
factor for the development of cardiovascular disease, stroke and all-cause mortality. Chronic …

Resistance to systemic therapies in clear cell renal cell carcinoma: mechanisms and management strategies

P Makhov, S Joshi, P Ghatalia, A Kutikov… - Molecular cancer …, 2018 - AACR
Renal cell carcinoma (RCC) is the most common form of kidney cancer. It is categorized into
various subtypes, with clear cell RCC (ccRCC) representing about 85% of all RCC tumors …

Small molecule NF-κB pathway inhibitors in clinic

V Ramadass, T Vaiyapuri, V Tergaonkar - International journal of …, 2020 - mdpi.com
Nuclear factor kappa B (NF-κB) signaling is implicated in all major human chronic diseases,
with its role in transcription of hundreds of gene well established in the literature. This has …

Targeted therapies in gynecological cancers: A comprehensive review of clinical evidence

Q Wang, H Peng, X Qi, M Wu, X Zhao - Signal Transduction and …, 2020 - nature.com
Advanced and recurrent gynecological cancers are associated with poor prognosis and lack
of effective treatment. The developments of the molecular mechanisms on cancer …

Analysis and visualization of quantitative proteomics data using FragPipe-Analyst

Y Hsiao, H Zhang, GX Li, Y Deng, F Yu… - Journal of Proteome …, 2024 - ACS Publications
The FragPipe computational proteomics platform is gaining widespread popularity among
the proteomics research community because of its fast processing speed and user-friendly …